`To:
`
`Cc:
`
`Subject:
`Date:
`
`Ansley, Sutton
`Dykhuis, Arthur; Arnie Calmann; Katherine A. Escanlar; jsoos@saiber.com; Carsten, Douglas; Steiner, Ellie;
`Litoshyk, Alina; nscharn@wsgr.com; jstephens@wsgr.com; atung@wsgr.com
`Cc: Liza Walsh; Katelyn O"Reilly; Christine Gannon; Mary Hogan; Weiswasser, Elizabeth; Vlasis, Robert; Desai,
`Anish; Pepe, Christopher; Kantha, Kathryn M.; Gesior, Andrew; Pereira, Aaron; Sieger, Matthew; Sanofi Mylan
`Lantus; William T. Walsh Jr; Dwyer, Anna
`Sanofi v. Mylan: Sanofi"s Responses to Mylan"s Amended Contentions
`Monday, August 13, 2018 8:40:35 PM
`
`Counsel,
`
`Sanofi provides herein its amended contentions pursuant to Local Rule 3.7 and the Court’s Orders
`[D.I. 100, D.I. 109, and D.I. 140], in response to Mylan’s Amended Invalidity Contentions, served on
`April 25, 2018. Sanofi will respond separately as to Biocon’s contentions and reserves the right to
`respond 45 days from the service thereof under Local Rule 3.6.
`
`Below please find FTP credentials for accessing Plaintiffs’ responsive amendments. I will send a
`password to access the encrypted files under separate cover.
`
`Please enter the address below into Internet Explorer to access the SFTP site:
`
`
`Best Regards,
`Sutton
`
`
`
`W. Sutton Ansley
`
`Weil, Gotshal & Manges LLP
`2001 M Street NW, Suite 600
`Washington, DC 20036
`sutton.ansley@weil.com
`+1 202 682 7018 Direct
`+1 202 857 0940 Fax
`
`
`
`Sanofi Exhibit 2011.001
`Mylan v. Sanofi
`IPR2018-01676
`
`